Sustainability Investors Products Research & Development Company Contact
Sustainability
ESG Environment Social
Investors
Reasons to invest Share information News Reports Corporate governance Stock exchange notices
Products
Salmon protein hydrolysate Salmon oil Calcium bone powder Collagen peptides European webshops
Research & Development
Our research All research programs Studies Clinical Trial Unit
Company
About us Our technology Operations Management Board of directors Awards
Contact
Sales Investor relations Factories Management
Type and search

All notices

Hofseth BioCare - Destruction of products

29.10.2012

HBC - Strengthens management team

09.10.2012

HBC - First GRAS-approval for ProGo completed

08.10.2012

Hofseth Biocare ASA - Enters distribution agreement for CalGo in North America

28.09.2012

Hofseth Biocare ASA - Changed financial calendar

24.09.2012

HBC - Mandatory notification of trade in Hofseth BioCare ASA

24.08.2012

HBC - Presentation material Q2 2012

22.08.2012

HBC - Second quarter 2012 results

22.08.2012

Hofseth BioCare - Invitation to presentation of 2nd quarter 2012 results

17.08.2012

HBC - Blackmores apply omeGO in development of new Omega-3 product

09.08.2012

Previous
24 25 26
27
28 29 30
Next
Sustainability
ESG Environment Social
Investors
Reasons to invest Share information News Reports Corporate governance Stock exchange notices
Products
Salmon protein hydrolysate Salmon oil Calcium bone powder Collagen peptides European webshops
Research & Development
Our research All research programs Studies Clinical Trial Unit
Company
About us Our technology Operations Management Board of directors Awards
Contact
Sales Investor relations Factories Management

Copyright 2021 Hofseth BioCare ASA
Privacy cookies